Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment
2018
Purpose of review
As cancer survivor rates improve with early screening and modern treatment options, cardiotoxicity is becoming an increasing problem. It is imperative for physicians to recognize adverse events early so that appropriate measures can be taken before advanced and permanent cardiac dysfunction ensues. In this review, we will evaluate the literature surrounding current cardiac biomarkers in the detection of cardiotoxicity during cancer treatment as well as discuss the role of emerging novel biomarkers.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
89
References
35
Citations
NaN
KQI